Maximising the IMPACT of university R&D/IP
The PIPE Platform and Lab to IPO Pathway gives universities a standard system, tools, processes and methodology to disclose, validate, launch, fund and future fund very early stage ideas.

The PIPE Platform and Lab to IPO Pathway gives universities a standard system, tools, processes and methodology to disclose, validate, launch, fund and future fund very early stage ideas.
Researchers and academics are not always incentivised to commercialise.
Determining the direction of travel is not always straightforward and simple.
A standard, systematic and easy to use platform enables more disclosures to be put forward, aligned with the researcher/academic’s timeline to publish, supports decision making, and simplifies the process.
Clear, well documented roadmaps are essential: based on evidence, supported by people who have been there before and know what they are doing, and properly funded.
A clear rationale for commercialisation, funding and equity early on is critical.
Ensuring there is a steady, reliable and timely source of capital ensures success.
Proving and recording the contributions of individuals, teams, the university and the founders means that these positions are protected while attracting new investors.
Capital must be aligned with the commercial roadmaps and direction of travel; key milestones ensure goals are hit and progress is made.
From simple user registration to project Disclosure & Validation, the PIPE Platform and Lab to IPO Pathway is designed to support the TTO and commercial team make better, standardised and systematic decisions. From the use of AI to the presentation of outcomes in a standard, easy to understand format, the PIPE Platform is a novel approach to university R&D/IP impact creation.
Researchers want to draft, peer review and publish without delay. At the same time, TTOs and commercial teams need to consider IP protection and/or a patent application. It takes time and money to investigate prior art, to identify the inventive step, and submit a patent application if appropriate. So there is a risk of conflict between these two work streams.